In a 4-year-old child with bilateral symmetric hypopigmented patches around the eyes and a depigmented area under the chin that began 4 months ago and previously improved with tacrolimus 0.03%, what is the most likely diagnosis and appropriate next steps in management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Vitiligo is the Most Likely Diagnosis

In this 4-year-old child with bilateral symmetric hypopigmented patches around the eyes and under the chin that began 4 months ago and responded to tacrolimus 0.03%, the diagnosis is vitiligo, and you should continue tacrolimus 0.03% ointment twice daily as first-line therapy.

Clinical Reasoning

The presentation is classic for vitiligo vulgaris (nonsegmental vitiligo) 1:

  • Bilateral symmetric distribution around the eyes (periocular) - a characteristic location for vitiligo
  • Depigmented/hypopigmented patches with no surface changes
  • Age of onset (4 years) - vitiligo commonly develops in childhood
  • Recent onset (4 months ago) - suggests active disease
  • Response to tacrolimus - confirms the diagnosis is likely vitiligo rather than other hypopigmentation disorders

The symmetrical periocular pattern strongly favors vitiligo over other conditions in the differential (pityriasis alba, post-inflammatory hypopigmentation, nevus depigmentosus, or tinea versicolor) 2.

Diagnostic Confirmation

Where vitiligo is classical with symmetrical distribution, diagnosis can be made clinically without requiring dermatology referral 1. However, consider:

  • Wood's lamp examination - will accentuate depigmented areas and help monitor treatment response 1
  • Thyroid function testing - check TSH and thyroid antibodies given the 34% prevalence of autoimmune thyroid disease in vitiligo patients 1
  • Photography - document baseline extent for monitoring progression 1

Treatment Protocol

Continue tacrolimus 0.03% ointment twice daily 1, 3:

  • Tacrolimus is specifically recommended for children with vitiligo as an alternative to potent topical steroids with a better short-term safety profile (Grade B/1+ evidence) 1
  • In pediatric vitiligo, tacrolimus achieves at least partial response in 89% of head/neck lesions and 63% of trunk/extremity lesions 3
  • Facial vitiligo shows the best response rates - highly relevant for this periocular presentation 3
  • Recent meta-analysis confirms 29% excellent improvement, 26% moderate improvement with minimal side effects in children 4

Expected Timeline and Side Effects

  • Onset of repigmentation: typically 2-4 months of consistent use
  • Common side effects: mild burning sensation (11%) or pruritus (9%) - usually transient 4
  • No systemic side effects reported in pediatric studies 4
  • No risk of skin atrophy unlike topical corticosteroids 1

Alternative if Tacrolimus Fails

If inadequate response after 3-4 months of tacrolimus:

  1. Potent topical corticosteroid (e.g., mometasone furoate) for maximum 2 months trial - but monitor for skin atrophy 1
  2. Consider no active treatment with camouflage cosmetics and sunscreens - appropriate option for lighter skin types after discussion with family 1
  3. Narrowband UVB phototherapy - reserved only for widespread disease or significant quality of life impact, not first-line in children 1

Critical Pitfalls to Avoid

  • Do not use potent steroids around the eyes long-term - risk of glaucoma, cataracts, and periocular skin atrophy
  • Do not delay thyroid screening - autoimmune thyroid disease is common and may require treatment
  • Do not promise complete repigmentation - periocular vitiligo can be challenging to treat
  • Do not overlook psychological impact - assess quality of life and offer counseling support for child and parents 1

Monitoring Plan

  • Clinical photographs every 2-3 months to document response 1
  • Wood's lamp examination to assess extent and repigmentation 1
  • Thyroid function tests at baseline (TSH, anti-thyroid antibodies) 1
  • Assess for new lesions - indicates active/progressive disease requiring more aggressive management

The rapid onset (4 months) and young age suggest this may be active, progressive vitiligo requiring consistent treatment to prevent further spread 5.

References

1
Guideline

guideline for the diagnosis and management of vitiligo.

British Journal of Dermatology, 2008

2
Research

Common Causes of Hypopigmentation in Children.

Pediatrics in review, 2025

Related Questions

In a 4‑year‑old child with bilateral symmetric hypopigmented patches around the eyes and a depigmented area under the chin being treated with tacrolimus 0.03 % ointment, can effective treatment result in no accentuation under Wood’s lamp even though the patches still appear hypopigmented and show no visible repigmentation?
What are the possible diagnoses for a 4-year-old child presenting with bilateral symmetric hypopigmented periorbital patches, a depigmented chin (mental) patch, congenital alopecia, lesions that began 4 months ago, and aggressive behavior?
What are the possible causes and recommended workup for a hypopigmented patch on the face?
In a 4‑year‑old child with new hypopigmented periorbital patches and a depigmented chin patch noted over the past 4 months, can congenital pigmentary disorders such as Waardenburg syndrome or piebaldism still be the cause despite the lesions not being present at birth?
A patient is currently taking a total of 7 mg of Envarsus (tacrolimus) once daily; how should the dose be adjusted based on his tacrolimus trough concentration?
What is the most likely diagnosis in a 7-month-old infant with a 2-day fever, red sore throat, and rash involving the chin, trunk, and hands?
Can acetaminophen be used for colicky pain in a patient with end-stage renal disease on hemodialysis who also has acute diarrheal illness?
Which patients with a closed left distal radius fracture require surgical stabilization?
How is suppurative thrombophlebitis diagnosed?
What is the appropriate dosing and administration of phenytoin for an adult with alcohol‑withdrawal–related seizures?
Why does vaginal dryness occur in postpartum women who are exclusively breastfeeding?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.